Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy

被引：6
作者：
Kam, Grace [1 ]
Yiu, Richard [1 ]
Loh, Yvonne [1 ,2 ]
Ang, Ai Leen [1 ,3 ]
Yueh, Ling Ling [1 ]
Goh, Yeow Tee [1 ]
Wong, Gee Chuan [1 ]
机构：
[1] Singapore Gen Hosp, Dept Haematol, Singapore 169608, Singapore
[2] Gleneagles Hosp, Asian Amer Blood & Marrow Transplant Ctr, Singapore 258500, Singapore
[3] Hlth Sci Author, Blood Serv Grp, Singapore 169078, Singapore
来源：
SUPPORTIVE CARE IN CANCER | 2015年 / 23卷 / 03期
关键词：
Pegylated filgrastim; Filgrastim; Acute myeloid leukaemia; Cytarabine; HIDAC; SINGLE-ADMINISTRATION PEGFILGRASTIM; COLONY-STIMULATING FACTOR; NEUTROPENIC PATIENTS; DOUBLE-BLIND; PHASE-III; MULTICENTER; ADULTS; INDUCTION; EFFICACY; UPDATE;
D O I：
10.1007/s00520-014-2417-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：643 / 649
页数：7
相关论文
共 20 条
[1]   Neutropenia-Associated Outcomes in Adults with Acute Myeloid Leukemia Receiving Cytarabine Consolidation Chemotherapy with or without Granulocyte Colony-Stimulating Factor [J].
Bradley, Amber M. ;
Deal, Allison M. ;
Buie, Larry W. ;
van Deventer, Hendrik .
PHARMACOTHERAPY, 2012, 32 (12) :1070-1077
[2]   Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG [J].
Braess, Jan ;
Spiekermann, Karsten ;
Staib, Peter ;
Grueneisen, Andreas ;
Woermann, Bernhard ;
Ludwig, Wolf-Dieter ;
Serve, Hubert ;
Reichle, Albrecht ;
Peceny, Rudolf ;
Oruzio, Daniel ;
Schmid, Christoph ;
Schiel, Xaver ;
Hentrich, Marcus ;
Sauerland, Christina ;
Unterhalt, Michael ;
Fiegl, Michael ;
Kern, Wolfgang ;
Buske, Christian ;
Bohlander, Stefan ;
Heinecke, Achim ;
Baurmann, Herrad ;
Beelen, Dietrich W. ;
Berdel, Wolfgang E. ;
Buechner, Thomas ;
Hiddemann, Wolfgang .
BLOOD, 2009, 113 (17) :3903-3910
[3]   A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule [J].
Derbel, Olfa ;
Cannas, Giovanna ;
Le, Quoc-Hung ;
Elhamri, Mohamed ;
Chelghoum, Youcef ;
Nicolas-Virelizier, Emmanuelle ;
Nicolini, Franck ;
Troncy, Jacques ;
Barraco, Fiorenza ;
Michallet, Mauricette ;
Thomas, Xavier .
HEMATOLOGY, 2010, 15 (03) :125-131
[4]  
Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073
[5]   A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy [J].
Green, MD ;
Koelbl, H ;
Baselga, J ;
Galid, A ;
Guillem, V ;
Gascon, P ;
Siena, S ;
Lalisang, RI ;
Samonigg, H ;
Clemens, MR ;
Zani, V ;
Liang, BC ;
Renwick, J ;
Piccart, MJ .
ANNALS OF ONCOLOGY, 2003, 14 (01) :29-35
[6]   Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques [J].
Harousseau, JL ;
Witz, B ;
Lioure, B ;
Hunault-Berger, M ;
Desablens, B ;
Delain, M ;
Guilhot, F ;
Le Prise, PY ;
Abgrall, JF ;
Deconinck, E ;
Guyotat, D ;
Vilque, JP ;
Casassus, P ;
Tournilhac, O ;
Audhuy, B ;
Solary, E .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :780-787
[7]   A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia [J].
Heil, G ;
Hoelzer, D ;
Sanz, MA ;
Lechner, K ;
Yin, JAL ;
Papa, G ;
Noens, L ;
Szer, J ;
Ganser, A ;
OBrien, C ;
Matcham, J .
BLOOD, 1997, 90 (12) :4710-4718
[8]   Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer [J].
Holmes, FA ;
O'Shaughnessy, JA ;
Vukelja, S ;
Jones, SE ;
Shogan, J ;
Savin, M ;
Glaspy, J ;
Moore, M ;
Meza, L ;
Wiznitzer, I ;
Neumann, TA ;
Hill, LR ;
Liang, BC .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :727-731
[9]   Management of fever in neutropenic patients with different risks of complications [J].
Klastersky, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 :S32-S37
[10]   Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy [J].
Lane, Steven W. ;
Crawford, Julie ;
Kenealy, Melita ;
Cull, Gavin ;
Seymour, John F. ;
Prince, H. Miles ;
Marlton, Paula ;
Gill, Devinder ;
Mollee, Peter N. .
LEUKEMIA & LYMPHOMA, 2006, 47 (09) :1813-1817
12